Electra Therapeutics, Inc. (ETRA) stock
Close on Nov 12, 2026Market cap $572.72MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $572.72M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.46
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $57.03
- Diluted shares
- 7M
Trading
- Previous close
- $9.45
- Open
- $9.53
- Day's range
- $8.67 – $9.88
- Volume
- 545,283
- Average volume (20 days)
- 375,172
- Relative volume
- 0.92×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ETRA | S&P 500 | Difference | ETRA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.3% | -2.7% | +0.4 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Electra Therapeutics stock: common questions
What is Electra Therapeutics's stock price?
ETRA closed at $9.11 on Nov 12, 2026, down 3.60% on the day.
What is Electra Therapeutics's market cap?
Electra Therapeutics was worth $572.72M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Electra Therapeutics pay a dividend?
No. Electra Therapeutics has not paid a cash dividend over the last twelve months.
How many ETRA shares are sold short?
0M shares were sold short at the latest FINRA report, 1.04% of the float, or 1.7 days of average trading volume.
Who are Electra Therapeutics's competitors?
Companies most similar to Electra Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.
See a number that looks wrong?